Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-07

Clinical Trial Update: Radiotherapy 12Gy in 6 Fractions For Orbital Lymphoma [NA]

View source ↗

Summary

A clinical trial is evaluating a radiotherapy regimen of 12 Gy delivered in 6 fractions for orbital lymphoma and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Orbital Lymphoma | NA | Status: NOT_YET_RECRUITING